Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$35.16
+0.2%
$1.90
$1.44
$8.18
$24.61M0.13935,975 shs1 shs
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
$8.05
-0.7%
$8.31
$5.01
$10.75
$10.42M0.9154,001 shs3,471 shs
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
$0.04
$0.04
$0.13
$0.38
$3.50M1.33338,444 shs1,022 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
+0.20%+0.84%-0.53%-0.51%+1,703.24%
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
-0.74%-1.11%+2.94%-0.74%+27.17%
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
+4.79%+1.55%-3.90%-1.50%-4.37%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
N/AN/AN/AN/A
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
2.00
HoldN/AN/A
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$10K2,461.42N/AN/A$1.26 per share27.91
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
$12.25M0.84$0.14 per share57.50$6.39 per share1.26
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
N/AN/AN/AN/A$0.20 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
-$8.09M-$1.68N/AN/AN/AN/A-104.96%-60.03%N/A
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
$160K$0.1173.19N/A0.51%2.01%1.21%5/20/2024 (Estimated)
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
-$6.64MN/A0.00N/AN/AN/A-64.66%-42.92%N/A

Latest EYEG, GHSI, and MATN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
N/A$0.33+$0.33$0.33N/A$21.56 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
N/AN/AN/AN/AN/A
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
N/AN/AN/AN/AN/A
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
N/AN/AN/AN/AN/A

Latest EYEG, GHSI, and MATN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2024
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.14845/1/20245/2/20245/7/2024
3/28/2024
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.15724/1/20244/2/20244/5/2024
2/29/2024
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.14863/1/20243/4/20243/7/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
0.01
3.07
3.07
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
N/A
9.01
6.98
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
N/A
0.17
0.17

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
64.16%
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
20.21%
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
0.07%

Insider Ownership

CompanyInsider Ownership
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
58.20%
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
1.32%
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
39.22%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
14700,0005.28 millionNot Optionable
Guardion Health Sciences, Inc. stock logo
GHSI
Guardion Health Sciences
91.28 million1.27 millionNot Optionable
Mateon Therapeutics, Inc. stock logo
MATN
Mateon Therapeutics
1390.24 millionN/ANot Optionable

EYEG, GHSI, and MATN Headlines

SourceHeadline
Viking Therapeutics Inc.Viking Therapeutics Inc.
wsj.com - February 27 at 5:16 PM
Professor: ‘Mathematics Itself Operates as Whiteness’Professor: ‘Mathematics Itself Operates as Whiteness’
nationalreview.com - April 4 at 9:12 AM
Sorrento Therapeutics Stock (OTC:SRNEQ), Quotes and News SummarySorrento Therapeutics Stock (OTC:SRNEQ), Quotes and News Summary
benzinga.com - February 25 at 11:29 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

AB Corporate Bond ETF logo

AB Corporate Bond ETF

NASDAQ:EYEG
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
Guardion Health Sciences logo

Guardion Health Sciences

NASDAQ:GHSI
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.
Mateon Therapeutics logo

Mateon Therapeutics

OTCMKTS:MATN
Mateon Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-beta, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; and CA4P for the treatment of advanced metastatic melanoma. The company is headquartered in Agoura Hills, California.